Congenital Rubella Syndrome: A Case Report

Ayodhia Pitaloka Pasaribu, Syahril Pasaribu, Irma Sari Nasution

2019

Abstract

Congenital rubella syndrome (CRS) is the effect of rubella virus infection during 8-12 weeks of gestation. In Indonesia, the incidence of CRS annually is 0.2/1000 live newborn. The most common defects of CRS are hearing defects (deafness), eye defects (cataract, congenital glaucoma), and cardiac defects (PDA). We reported a case of congenital rubella syndrome in a 5-month-old boy. He was first diagnosed with congenital rubella syndrome 4 months ago (confirmed by positive of anti-rubella IgM with congenital cataract and congenital heart disease-PDA and ASD). He was admitted to Adam Malik Hospital due to congestive heart failure Ross III, bronchopneumonia, marasmus, and anemia. We treated the patient with bed rest, oxygen supplementation, broad-spectrum empiric antibiotics, antipyretic, diuretic, angiotensin converting enzyme inhibitor, and nutritional management according to pediatric nutrition.

Paper Citation

in Harvard Style

Pasaribu A., Pasaribu S. and Nasution I. (2019). Congenital Rubella Syndrome: A Case Report.In Proceedings of the 2nd International Conference on Tropical Medicine and Infectious Disease - Volume 1: ICTROMI, ISBN 978-989-758-469-5, pages 111-114. DOI: 10.5220/0009861501110114

in Bibtex Style

@conference{ictromi19,
author={Ayodhia Pitaloka Pasaribu and Syahril Pasaribu and Irma Sari Nasution},
title={Congenital Rubella Syndrome: A Case Report},
booktitle={Proceedings of the 2nd International Conference on Tropical Medicine and Infectious Disease - Volume 1: ICTROMI,},
year={2019},
pages={111-114},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0009861501110114},
isbn={978-989-758-469-5},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 2nd International Conference on Tropical Medicine and Infectious Disease - Volume 1: ICTROMI,
TI - Congenital Rubella Syndrome: A Case Report
SN - 978-989-758-469-5
AU - Pasaribu A.
AU - Pasaribu S.
AU - Nasution I.
PY - 2019
SP - 111
EP - 114
DO - 10.5220/0009861501110114